Introduction
============

Usher syndrome (OMIM [276900](http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=276900)--2; OMIM [276905](http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=276905); OMIM [605472](http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=605472)) is the most common cause of genetic deafblindness. This syndrome follows an autosomal recessive pattern of inheritance and is characterized by retinitis pigmentosa (RP), sensorineural hearing impairment, and in some cases vestibular dysfunction. Three clinical types can be distinguished \[[@r1]\]. Patients with Usher syndrome type I (USH1) show severe to profound congenital hearing loss, early onset RP, and vestibular areflexia. Patients with type II (USH2) suffer from moderate to severe congenital hearing loss, onset of RP around puberty or in adulthood, but normal vestibular function. Usher type III (USH3) patients present with progressive hearing loss, RP, and variable vestibular function. Furthermore, some Usher syndrome patients cannot be classified into any of these three subtypes and are considered atypical Usher (USHA) patients. To date, nine genes are known to be involved in USH: *MYO7A* (USH1B), *USH1C, CDH23* (USH1D), *PCDH15* (USH1F), and *USH1G* for USH1; *USH2A*, *GPR98* (USH2C), and *DFNB31* (USH2D) for USH2; and *USH3A* for USH3 \[[@r2]-[@r14]\]. The eight genes responsible for USH1 and USH2 encode proteins that interact in a functional network.

The *DFNB31* gene was initially found to be responsible for recessive nonsyndromic sensorineural hearing impairment (NSHI), underlying the *DFNB31* locus \[[@r15]\]. *DFNB31* comprises 12 exons and encodes the whirlin protein. Two isoforms of whirlin are known. The short isoform is encoded by exons 6--12 and contains one PDZ domain (PDZ3) and a proline-rich region. The long isoform is encoded by all 12 *DFNB31* exons and contains three PDZ domains (PDZ1, PDZ2, and PDZ3) and a proline-rich region \[[@r15]\]. PDZ1 and PDZ2 have been shown to interact with usherin, myosin VIIa, G-Protein coupled Receptor 98 (GPR98), Scaffold protein containing Ankyrin repeats and SAM domain (SANS), and myosin XVa, while PDZ3 interacts only with myosin XVa \[[@r16]-[@r18]\]. All these findings made *DFNB31* an excellent candidate for Usher syndrome. More recently, Ebermann et al. \[[@r14]\] described a novel genetic subtype for Usher syndrome type II (USH2D) caused by truncating mutations in the long isoform of whirlin.

The protein whirlin is thought to play an important role in the elongation of stereocilia and development of cochlear hair cells and has been demonstrated to be the major scaffold protein of an Usher protein network in the ankle link complex of inner hair cells \[[@r15],[@r17],[@r19]\]. In the retina, whirlin is a key partner of another USH interactome in the periciliary region of photoreceptor cells. This Usher protein network is hypothesized to be essential for the regulation of cargo transfer from the photoreceptor inner segment to the outer segment by the ciliary transport system \[[@r18]\].

The recent finding that mutations in *DFNB31* cause USH2 prompted us to screen the 12 exons of this gene in 195 patients from diverse origins who have USH1, USH2, and USHA. Our aim was to elucidate the prevalence of *DFNB31* mutations in the pathogenesis of USH.

Methods
=======

Patients
--------

We included 149 patients with USH2, 29 patients with USH1, and six patients with USHA in this study. Furthermore, 11 unclassified USH patients were included from whom clinical data were not available. Of the 195 unrelated patients, 74 were of Spanish origin, 47 of German, 39 of Dutch, 17 of Hungarian, and 13 of other different origins (see [Table 1](#t1){ref-type="table"}).

###### Clinical classification of USH patients.

  **Origin**        **USH1**   **USH2**   **USHA**   **USH NC\***   **Total**
  ----------------- ---------- ---------- ---------- -------------- -----------
  The Netherlands   0          27         2          10             39
  Spain             21         51         2          0              74
  Germany           2          44         0          1              47
  Hungary           2          13         2          0              17
  Canada            1          4          0          0              5
  Russia            1          2          0          0              3
  Arabia            0          1          0          0              1
  Egypt             2          2          0          0              4
  Turkey            0          3          0          0              3
  Unknown           0          2          0          0              2
  Total             29         149        6          11             195

\*USH NC: Clinical data not available to classify the patients into any subtype.

Most of these patients were selected for *DFNB31* screening after discarding the presence of pathologic mutations in the most prevalent USH genes. Of the 195 patients, 116 patients correspond to those briefly mentioned in previous studies \[[@r13],[@r16]\]. Clinical diagnosis of Usher syndrome patients was performed in different hospitals according to standard ophthalmologic, otorhinolaryngologic, and electroretinographic procedures. Written informed consent was obtained for each participant, and the study was approved by the review board of the Ethics Committee of each institution that participated in this work.

Mutation screening
------------------

Venous blood samples were obtained and genomic DNA was extracted by standard protocols \[[@r7]\]. For mutation analysis of *DFNB31*, the 12 coding exons were PCR amplified using primers located in flanking introns and untranslated region (UTR) sequences ([Table 2](#t2){ref-type="table"}). PCR products were directly sequenced using standard procedures ([Table 2](#t2){ref-type="table"}). The obtained sequences were compared with the consensus sequence [NM_015404](http://www.ncbi.nlm.nih.gov/nuccore/140561023).

###### Primer sequences for the amplification of the coding region of *DFNB31*.

  **Primer name**           **Sequence (5′-3′)**      **Annealing temperature**
  ------------------------- ------------------------- ---------------------------
  Exon 1                    F: CAGCAGCCAACTCTTGTGTC   55 °C
  R: CCAGAAAGGCCAAGTGATTC                             
  Exon 2                    F: ACTCCCCAAATCCAAGTTCC   58 °C
  R: CAGAACCAGCCTCTTCTTGC                             
  Exon 3                    F: CTCCTTGCCAGTCGGATAAG   55 °C
  R: GAGTGCTGATTGCTCTGCTG                             
  Exon 4                    F: ATAAGGGGACCCTTGGAATG   55 °C
  R: TCCCCACTTTTTGGATGAAG                             
  Exon 5                    F: GTCCGGAGTTTCCTTTACCC   55 °C
  R: TGGTCTGCTCTGTTCATTGC                             
  Exon 6                    F: TGGCAATGAACAGAGCAGAC   58 °C
  R: GGAGGGCTTGTGAAGATGAC                             
  Exon 7                    F: GACAGGGAAGCAGGAGTGAG   58 °C
  R: GATTCGAACTCAGGCTGGTC                             
  Exon 8                    F: CAGCATCTCTGGCAGTTCAG   58 °C
  R: GGCTGTCATGGAGAGGAGAG                             
  Exon 9                    F: GTGACAAGCTCTGGCTGATG   58 °C
  R: TTCAAACTGGGGTCTCCAAC                             
  Exon 10                   F: GGTCTGGTTGAAAGGACAGG   58 °C
  R: GGCCTCCAGATTCCTAATCC                             
  Exon 11                   F: GAGGCTGAGATTGGTCTTGG   55 °C
  R: CCTAGGTCTGCCCTTGAGTG                             
  Exon 12                   F: CCCTTTCTCAGCATCTCCAG   58 °C
  R: GTCTGCCTTGTCCTGCTCTC                             

Amplification conditions were 95 °C 5 min followed by 35 cycles of 30 s at 95 °C, 30 s at an annealing temperature specific for each exon (column 3) and 30 s at 72 °C.

Isocoding and missense changes found in a low frequency were analyzed with the program [RESCUE-ESE](http://genes.mit.edu/burgelab/rescue-ese) (Christopher Burge Laboratory, Massachusetts Institute of Technology; Cambridge, MA). This program predicts the creation or elimination of exonic splicing enhancer sites (ESEs).

To assess the effect of the amino acid substitutions on the protein and to study the degree of interspecies amino acid conservation we used the software Alamut v1.5 Interactive Biosoftware (Rouen, France).

Intronic, isocoding, and missense changes were also analyzed using the programs [NNSPLICE](http://fruitfly.org:9005/seq_tools/splice.html) (Berkeley Drosophila Genome Project \[BDGP\] University of California Berkeley; Berkeley, CA) and [Splice View](http://bioinfo.itb.cnr.it/oriel/splice-view.html) (Institute of Biomedical Technologies, Milano, Italy) to predict if those changes could be affecting, creating, or eliminating donor/acceptor splice sites.

Results
=======

Mutation screening of *DFNB31* in 195 USH patients of diverse origins identified 38 different sequence variants: eight synonymous, 15 missense, and 15 intronic variants. Most of these changes are clearly polymorphic as they were detected in high frequencies and represent known single nucleotide polymorphisms (SNPs). Twelve sequence variants were found only once in our series, five changes were found twice, one variant was identified in three alleles, and another one in four (see [Table 3](#t3){ref-type="table"}). None of these 19 rare changes were found in the homozygous state or in trans to another putatively pathogenic variation.

###### Variants detected in this study

  **Nucleotide change**   **SNP**                                                                          **Exon**   **Amino acid change**   **Protein location**   **Number of alleles**   **Allele frequency**   **Homozygotes**   **Heterozygotes**   **Origin**
  ----------------------- -------------------------------------------------------------------------------- ---------- ----------------------- ---------------------- ----------------------- ---------------------- ----------------- ------------------- ---------------------------
  **Isocoding**                                                                                                                                                                                                                                           
  c.117G\>A               [rs2297815](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2297815)     1          None                    LC1-PDZ1               111                     0.383                  20                71                  N, S, G, H, C, R, T, A, E
  c.1353T\>Ca             [rs4979387](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4979387)     6          None                    PDZ2-LC2               263                     0.674                  96                71                  N,S, G, H, C, R, T, E
  c.1455G\>A                                                                                               7          None                    PDZ2-LC2               4                       0.01                   0                 4                   N, G
  c.1486C\>T                                                                                               7          None                    PDZ2-LC2               1                       0.003                  0                 1                   Unknown
  c.1515G\>A              [rs34252199](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=34252199)   7          None                    PDZ2-LC2               10                      0.026                  0                 10                  S, G, H
  c.1886G\>A                                                                                               9          None                    LC3                    18                      0.046                  6                 6                   S, N
  c.2283C\>T              [rs34963246](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=34963246)   10         None                    LC3-PDZ3               30                      0.077                  3                 24                  S, G, H, S, C, T
  c.2307C\>T                                                                                               10         None                    LC3-PDZ3               2                       0.005                  0                 2                   S, G
  **Missense**                                                                                                                                                                                                                                            
  c.229A\>T               [rs56204273](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=56204273)   1          p.T77S                  Between LC1-PDZ1       1                       0.003                  0                 1                   N
  c.1048C\>T                                                                                               4          p.R350W                 PDZ2                   1                       0.003                  0                 1                   E
  c.1148C\>A                                                                                               4          p.T383N                 Between PDZ2-LC2       2                       0.005                  0                 2                   N
  c.1148C\>G                                                                                               4          p.T383S                 Between PDZ2-LC2       1                       0.003                  0                 1                   S
  c.1309G\>A                                                                                               6          p.A437T                 Between PDZ2-LC2       6                       0.015                  0                 6                   S
  c.1318G\>A              [rs4978584](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4979387)     6          p.A440T                 Between PDZ2-LC2       88                      0.226                  16                55                  N, S, G, C, R, T, E
  c.1339G\>A              6                                                                                p.D447H    Between PDZ2-LC2        1                      0.003                   0                      1                 H                    
  c.1684C\>G              [rs12339210](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=12339210)   8          p.P562A                 Between LC2-LC3        39                      0.1                    2                 35                  N, S, G, H, C, R, T, E
  c.1838T\>Ca             [rs942519](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=942519)       9          p.M613T                 Between LC2-LC3        179                     0.459                  45                89                  N, S, G, H, C, R, T, E
  c.1884C\>A              9                                                                                p.S628R    LC2                     1                      0.003                   0                      1                 E                    
  c.1943C\>A              9                                                                                p.S648Y    Between LC3-PDZ3        1                      0.003                   0                      1                 S                    
  c.2169G\>A              9                                                                                p.M723I    Between LC3-PDZ3        1                      0.003                   0                      1                 H                    
  c.2348T\>C\*            [rs2274159](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2297815)     10         p.V783A                 Between LC3-PDZ3       153                     0.392                  30                93                  N, S, G, H, C, R, T, E
  c.2388C\>A              [rs2274158](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274158)     10         p.N796K                 Between LC3-PDZ3       85                      0.218                  11                63                  N, S, G, H, C, R, T, E
  c.2644C\>A                                                                                               12         p.R882S                 PDZ3                   1                       0.003                  0                 1                   S
  **Intronic**                                                                                                                                                                                                                                            
  c.619--41A\>G                                                                                            2          None                                           1                       0.003                  0                 1                   H
  c.837+41A\>G                                                                                             2          None                                           2                       0.005                  0                 2                   E, unknown
  c.964--21A\>G           [rs2274163](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274163)     4          None                                           114                     0.292                  14                86                  N, S, G, H, C, C, R, T, E
  c.1203+114C\>T                                                                                           5          None                                           2                       0.005                  0                 2                   S
  c.1416+151A\>G          [rs4979385](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4979385)     6          None                                           19                      0.049                  2                 15                  S
  c.1416+62delC                                                                                            6          None                                           1                       0.003                  0                 1                   S
  c.1416+22A\>T           [rs4979386](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=4979386)     6          None                                           77                      0.197                  8                 61                  N, S, G, H, C, T, E
  c.1627--12G\>A          [rs2274160](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2274160)     8          None                                           68                      0.174                  5                 19                  N, S, G, H, C, R, T, A, E
  c.2236+84G\>T           [rs10982200](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10982200)   9          None                                           8                       0.021                  0                 8                   G, H
  c.2237--44C\>T          [rs766835](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=766835)       10         None                                           3                       0.008                  0                 3                   N
  c.2418+142A\>G          [rs10739410](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=10739410)   10         None                                           29                      0.074                  5                 19                  N, S
  c.2419--199A\>G                                                                                          11         None                                           18                      0.046                  5                 8                   N, S
  c.2419--118G\>A         [rs55833018](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=55833018)   11         None                                           12                      0.031                  0                 12                  S
  c.2419--16T\>C                                                                                           11         None                                           1                       0.003                  0                 1                   G
  c.2644--157C\>T                                                                                          12         None                                           2                       0.005                  0                 2                   G, S

The asterisk indicates previously reported as polymorphism by Tlili et al. \[[@r20]\]. Abbreviations: N represents The Netherlands, S represents Spain, G represents Germany, H represents Hungary, C represents Canada, R represents Russia, T represents Turkey, A represents Arabia), E represents Egypt, LC represents Low complexity protein domain.

Isocoding changes
-----------------

Only three out of the eight silent changes were found with an allele frequency ≤0.01 (see [Table 3](#t3){ref-type="table"} for more details). Variant c.1486C\>T was only found in one USH2 patient from uncertain origin, and c.2307C\>T was found in one USH1 patient from Spain and in one USH2 patient from Germany. Variant c.1455G\>A was detected in four alleles of patients from the Netherlands and Germany. These three rare isocoding variants were analyzed using the [RESCUE-ESE](http://genes.mit.edu/burgelab/rescue-ese/) program, but none were found to create or eliminate any ESEs.

These three changes were also analyzed with NNSPLICE and Splice View. Both programs predicted the creation of one new donor site when introducing the change c.2307C\>T (NNSPLICE score of 0.66 \[0.00--1.00\] and Splice View score of 86 \[0--100\])

Missense changes
----------------

From the 15 missense variants detected, only p.T77S, p.R350W, p.T383N, p.T383S, p.D447H, p.S628R, p.S648Y, p.M723I, and p.R882S showed a frequency ≤0.01 (see [Table 3](#t3){ref-type="table"}).

These nine variants were analyzed using the [Alamut program](http://www.interactive-biosoftware.com/Alamut-brochure.pdf). For two of these changes (p.R350W and p.R882S), this program predicted possible implications in protein structure and function. The amino acid substitution p.R350W (c.1048C\>T) affected a highly conserved nucleotide at the cDNA level with a score of 0.9 (0--1). The amino acid conservation among 13 species was moderate, and the Grantham distance between amino acids Arg and Trp was 101 (0--215). Furthermore, this variation was found to be located in the PDZ2 protein domain. The change p.R882S (c.2644C\>A at the cDNA level) affects a highly conserved nucleotide (score 1.0 \[0--1\]) and an amino acid highly conserved up to the fruit fly (considering 13 species). The physicochemical difference between Arg and Ser was found to be moderate since a Grantham distance of 110 (0--215) was obtained. Also this variation was located in the PDZ3 domain.

These nine rare missense variants were further evaluated for an effect on exonic splice enhancers by using the [RESCUE-ESE](http://genes.mit.edu/burgelab/rescue-ese/) program. The change c.1148C\>A (p.T383N), found in two unrelated USH2 patients from the Netherlands, creates four new putative ESE sites, whereas c.1339G\>A (p.D447H), detected in one USH2 patient from Hungary, suppresses one existing ESE sequence and creates two new putative ESE sites. The remaining variants were not found to affect any ESE site.

These changes were also analyzed with NNSPLICE and Splice View, but neither was found to affect, create, or eliminate any donor or acceptor splice site.

Intronic changes
----------------

All intronic variants were detected in frequencies ≥0.01, except for c.619--41A\>G, c.837+41A\>G, c.1203+114C\>T, c.1416+62delC, c.2237--44C\>T ([rs766835](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=766835)), c.2419--16T\>C, and c.2644--157C\>T ([Table 3](#t3){ref-type="table"}). None of these changes were predicted to affect or create splice donor or splice acceptor sites in the analysis with the NNSPLICE and Splice View programs.

Discussion
==========

To date only one Usher family with clearly pathogenic, truncating, *DFNB31* mutations has been described \[[@r14]\]. Here, we describe additional sequence variants in USH patients tested for mutations in *DFNB31* and discuss their putative pathologic effects.

A total of 38 different variants were found in the *DFNB31* sequence, but no variant was a frameshift or a nonsense change. Out of these, 19 rare variants were found with allelic frequency ≤0.01; two of them were located in PDZ protein domains (p.R350W and p.R882S), and four were predicted to create or abrogate splice sites (c.2307C\>T, p.T383N, p.D447H, and p.R882S).

By the introduction of p.R350W and p.R882S, uncharged amino acids may affect the three-dimensional structure of the protein, which is important for the adequate function of interacting domains. Furthermore, both the amino acids R350 and R882 were well conserved throughout evolution, indicating these residues have an important role in protein structure and function. All these factors point to a possible pathologic effect for these two variants.

Segregation analysis for the variants p.R350W, p.G769G, p.T383N, and p.D447H could not be performed. In some cases, we only had a DNA sample from a patient without any family history. In other cases, the patient was a sporadic case and segregation analysis did not reveal any information about the pathogenicity of the variant (e.g., in the case of p.R882S). We found variant p.R882S in a sporadic Spanish USH2 patient together with the variant p.S648Y. Segregation analysis for these changes was performed in healthy relatives and revealed that both variants were located on the same allele. In addition, p.R882S and p.S648Y were present in the patient, in his healthy brother and sister, and in his two healthy children.

To explore the possibility of yet unidentified exons of *DFNB31*, which may contain mutations in the second allele of patients with a potentially pathogenic mutation on one allele, we performed an in silico search by using [Geneid](http://genome.crg.es/geneid.html) (Genome Bioinformatics Research Lab; Center for Genomic Regulation, Barcelona, Spain), [N-SCAN](http://www.nscan.org/) (Computational Genomics Laboratory; Washington University of St. Louis, St. Louis; MO) and we also searched in the [UCSC Genome Browser](http://genome.ucsc.edu/) (University of California Santa Cruz Genome Bioinformatics Web Site, Santa Cruz, CA), but no additional exons were predicted in the DFNB31 locus.

In summary, this study did not reveal evidence for the involvement of *DFNB31* mutations in 195 unrelated USH patients. However, total or partial gene deletions and duplications can escape the screening method applied herein and therefore cannot be excluded. Our results indicate a minor causative role for *DFNB31* in Usher syndrome. However, modifying effects of the variants we detected might contribute to the phenotype of Usher syndrome.

Regarding the implication of this gene in nonsyndromic hearing loss, the studies performed so far also indicate that DFNB31 is a rare form of deafness \[[@r15],[@r20]\]. We previously hypothesized that *DFNB31* mutations may also be causative for nonsyndromic retinal degenerations. This remains to be confirmed.
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